000 | 01987 a2200517 4500 | ||
---|---|---|---|
005 | 20250516111507.0 | ||
264 | 0 | _c20130122 | |
008 | 201301s 0 0 eng d | ||
022 | _a1932-6203 | ||
024 | 7 |
_a10.1371/journal.pone.0044572 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aJung, Jae-Joon | |
245 | 0 | 0 |
_aSecretion of soluble vascular endothelial growth factor receptor 1 (sVEGFR1/sFlt1) requires Arf1, Arf6, and Rab11 GTPases. _h[electronic resource] |
260 |
_bPloS one _c2012 |
||
300 |
_ae44572 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aADP-Ribosylation Factor 1 _xantagonists & inhibitors |
650 | 0 | 4 | _aADP-Ribosylation Factor 6 |
650 | 0 | 4 |
_aADP-Ribosylation Factors _xantagonists & inhibitors |
650 | 0 | 4 |
_aAmino Acids _xmetabolism |
650 | 0 | 4 |
_aBrefeldin A _xpharmacology |
650 | 0 | 4 | _aCell Line, Tumor |
650 | 0 | 4 |
_aEndoplasmic Reticulum _xdrug effects |
650 | 0 | 4 |
_aGene Expression _xdrug effects |
650 | 0 | 4 |
_aGolgi Apparatus _xdrug effects |
650 | 0 | 4 | _aHuman Umbilical Vein Endothelial Cells |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aPlasmids |
650 | 0 | 4 | _aProtein Structure, Tertiary |
650 | 0 | 4 |
_aProtein Synthesis Inhibitors _xpharmacology |
650 | 0 | 4 |
_aProtein Transport _xdrug effects |
650 | 0 | 4 |
_aRNA, Small Interfering _xgenetics |
650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
650 | 0 | 4 | _aSolubility |
650 | 0 | 4 | _aSulfur Radioisotopes |
650 | 0 | 4 | _aTransfection |
650 | 0 | 4 |
_aVascular Endothelial Growth Factor Receptor-1 _xgenetics |
650 | 0 | 4 |
_arab GTP-Binding Proteins _xantagonists & inhibitors |
700 | 1 | _aTiwari, Ajit | |
700 | 1 | _aInamdar, Shivangi M | |
700 | 1 | _aThomas, Christie P | |
700 | 1 | _aGoel, Apollina | |
700 | 1 | _aChoudhury, Amit | |
773 | 0 |
_tPloS one _gvol. 7 _gno. 9 _gp. e44572 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1371/journal.pone.0044572 _zAvailable from publisher's website |
999 |
_c22090327 _d22090327 |